Expression and characterization of bovine lactoperoxidase by recombinant vaccinia virus

被引:0
|
作者
Tanaka, Tetsuya [1 ,4 ]
Xuan, Xuenan [2 ]
Kojima, Asato [3 ]
Igarashi, Ikuo [2 ]
Fujisaki, Kozo [1 ,2 ]
Shimazaki, Kei-ichi [4 ]
机构
[1] Kagoshima Univ, Lab Emerging Infect Dis, Dept Frontier Vet Sci, Fac Agr, Kagoshima 8900065, Japan
[2] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080855, Japan
[3] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan
[4] Hokkaido Univ, Res Fac Agr, Lab Dairy Food Sci, Sapporo, Hokkaido 0608589, Japan
基金
日本学术振兴会;
关键词
Lactoperoxidase; Lactoferrin; N-linked glycosylation; Vaccinia virus; Antiviral effects;
D O I
10.1007/s10616-009-9181-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lactoperoxidase (LPO) is a 78 kDa heme-containing oxidation-reduction enzyme present in milk, found in physiological fluids of mammals. LPO has an antimicrobial activity, and presumably contribute to the protective functions of milk against infectious diseases. In this study, recombinant vaccinia virus expressing bovine LPO (vv/bLPO) was constructed. In rabbit kidney (RK13) cells infected with vv/bLPO, recombinant bLPO was detected in both cell extracts and culture supernatants. Tunicamycin treatment decreased the molecular weight of recombinant bLPO, indicating that recombinant bLPO contains a N-linked glycosylation site. The replication of recombinant vaccinia viruses expressing bovine lactoferrin (vv/bLF) at a multiplicity of infection (moi) of 5 plaque-forming units (PFU)/cell was inhibited by antiviral activity of recombinant bLF, suggesting that vv/bLF has an antiviral effect against vaccinia virus. On the other hand, the replication of vv/bLPO at a moi of 5 PFU/cell was not inhibited by antiviral activity of recombinant bLPO, indicating that this recombinant virus could be used as a suitable viral vector. These results indicate that a combination of bLPO and vaccinia virus vector may be useful for medical and veterinary applications in vivo.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 50 条
  • [31] Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
    Czub, M
    Weingartl, H
    Czub, S
    He, RT
    Cao, JX
    VACCINE, 2005, 23 (17-18) : 2273 - 2279
  • [32] MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis
    Roque-Reséndiz, JL
    Rosales, R
    Herion, P
    PARASITOLOGY, 2004, 128 : 397 - 405
  • [33] Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
    Noy-Porat, Tal
    Tamir, Hadas
    Alcalay, Ron
    Rosenfeld, Ronit
    Epstein, Eyal
    Cherry, Lilach
    Achdout, Hagit
    Erez, Noam
    Politi, Boaz
    Yahalom-Ronen, Yfat
    Weiss, Shay
    Melamed, Sharon
    Israely, Tomer
    Mazor, Ohad
    Paran, Nir
    Makdasi, Efi
    MICROBIOLOGY SPECTRUM, 2023,
  • [34] Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
    Noy-Porat, Tal
    Tamir, Hadas
    Alcalay, Ron
    Rosenfeld, Ronit
    Epstein, Eyal
    Cherry, Lilach
    Achdout, Hagit
    Erez, Noam
    Politi, Boaz
    Yahalom-Ronen, Yfat
    Weiss, Shay
    Melamed, Sharon
    Israely, Tomer
    Mazor, Ohad
    Paran, Nir
    Makdasi, Efi
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [35] Enteric immunization against influenza with a replication-deficient recombinant vaccinia virus
    Taylor, SF
    Rowe, CA
    Wyatt, LS
    Moss, B
    Small, PA
    Bender, BS
    OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 278 - 284
  • [36] Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus
    X. Xuan
    A. Kojima
    T. Murata
    T. Mikami
    H. Otsuka
    Archives of Virology, 1997, 142 : 1003 - 1010
  • [37] BIOLOGICAL EFFECTS OF RECOMBINANT VACCINIA VIRUS-EXPRESSED INTERLEUKIN-4
    ANDREW, ME
    COUPAR, BEH
    CYTOKINE, 1992, 4 (04) : 281 - 286
  • [38] HIGH-LEVEL EXPRESSION OF HUMAN NEUROPEPTIDE-Y RECEPTORS IN MAMMALIAN-CELLS INFECTED WITH A RECOMBINANT VACCINIA VIRUS
    WALKER, P
    MUNOZ, M
    COMBE, MC
    GROUZMANN, E
    HERZOG, H
    SELBIE, L
    SHINE, J
    BRUNNER, HR
    WAEBER, B
    WITTEK, R
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1993, 91 (1-2) : 107 - 112
  • [39] EXPRESSION AND CELLULAR-LOCALIZATION OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS-N AND M-PROTEINS BY RECOMBINANT VACCINIA VIRUSES
    PULFORD, DJ
    BRITTON, P
    VIRUS RESEARCH, 1991, 18 (2-3) : 203 - 217
  • [40] Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes
    Deng, Yining
    Navarro-Forero, Santiago
    Yang, Zhilong
    MBIO, 2025,